Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Verrica Pharmaceuticals Inc
(NQ:
VRCA
)
13.46
USD
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 12, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Verrica Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Verrica Pharmaceuticals Announces Participation in the 20th Annual Needham Virtual Healthcare Conference
April 06, 2021
From
GlobeNewswire News Releases
Last Week's Notable Insider Buys: PennyMac Financial, Republic Services And More
April 04, 2021
Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. Insider buying can be...
Tags
Technology
Market News
Services
From
Blogs - TalkMarkets
Last Week's Notable Insider Buys: PennyMac Financial, Republic Services And More
April 03, 2021
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Yet again, ...
Tags
omega healthcare investors
PennyMac Financial Services
Insider Trades
From
Benzinga
Verrica Announces Election of Gary Goldenberg, MD, Verrica’s Chief Medical Officer, to Membership in the American Dermatological Association
March 29, 2021
From
GlobeNewswire News Releases
Investors Snag VRCA Even Lower Than Its Secondary Stock Offering
March 24, 2021
Looking back to 2 days ago, Verrica Pharmaceuticals Inc (VRCA) priced a 2,033,899 share secondary stock offering at $14.75 per share. Buyers in that offering made a considerable investment into the...
Tags
Stocks
From
Market News Video
The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO
March 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
NVO
HRMY
Earnings
From
Benzinga
Verrica Announces Pricing of Public Offering of Common Stock
March 22, 2021
From
GlobeNewswire News Releases
Verrica Announces Proposed Public Offering of Common Stock
March 22, 2021
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes
March 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
SVRA
CELC
SRRA
From
Benzinga
Verrica Pharmaceuticals Announces Exclusive Licensing Agreement With Torii Pharmaceutical Co., Ltd. To Develop and Commercialize VP-102 For Molluscum and Common Warts in Japan
March 17, 2021
Torii to make upfront payment of $11.5 million to Verrica in addition to other potential milestone payments of up to $58 million and, if marketed in Japan, tiered transfer price payments as a...
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Novavax Vaccine Data, ContraFect Secures BARDA Funding, 2 IPOs
March 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
LGVN
ALT
CEMI
From
Benzinga
Stocks That Hit 52-Week Highs On Thursday
March 11, 2021
On Thursday morning, 420 companies hit new 52-week highs. Significant Points: The largest company by market cap to ...
Tags
SAL
USFD
TPC
From
Benzinga
The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena
March 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
VRCA
FDA
OCUL
From
Benzinga
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial Results
March 04, 2021
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright Annual Global Life Sciences Conference
March 03, 2021
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Announces Participation in the Cowen 41st Annual Health Care Conference
February 23, 2021
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
February 17, 2021
From
GlobeNewswire News Releases
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
SGEN
ARWR
Offerings
From
Benzinga
Stocks That Hit 52-Week Highs On Tuesday
February 09, 2021
On Tuesday, 596 companies set new 52-week highs. Intriguing Points: PayPal Holdings (NASDAQ:PYPL) was the ...
Tags
TTI
VFF
TTGT
From
Benzinga
Verrica Pharmaceuticals Presents Positive Data From Clinical Studies Evaluating the Safety and Efficacy of VP-102 in Molluscum and External Genital Warts at the 2021 Winter Clinical Dermatology Confer
January 19, 2021
From
GlobeNewswire News Releases
Biggest Price Target Changes For Thursday
December 24, 2020
Morgan Stanley lifted the price target for Paychex, Inc. (NASDAQ: PAYX) from $76 to $91. Paychex shares rose 0.2% to $94.55 in ...
Tags
Market News
Price Target
Small Cap
From
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 23, 2020
Gainers Bellicum Pharmaceuticals (NASDAQ:BLCM) shares rose 9.91% to $4.1 during Wednesday's after-market session. Trading volume ...
Tags
IMAB
Health Care
CMPI
From
Benzinga
Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
December 23, 2020
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Announces Receipt of Final FDA Minutes Following Type A Meeting Regarding Resubmission of the NDA for VP-102 in Molluscum
November 17, 2020
- Verrica reaffirms expectation to resubmit its New Drug Application for VP-102 for the treatment of molluscum in the first quarter of 2021 -
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Announces Participation in the Jefferies Virtual London Healthcare Conference
November 12, 2020
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Announces Positive Topline Results in Phase 2 Clinical Study of VP-102 in Patients with External Genital Warts (CARE-1)
November 10, 2020
From
GlobeNewswire News Releases
Verrica Pharmaceuticals Reports Third Quarter 2020 Financial Results
November 09, 2020
From
GlobeNewswire News Releases
Analysts See 13% Gains Ahead For The Holdings of VHT
October 20, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Gore Range Capital Bolsters Advisory Board for Skin Health Investments
October 13, 2020
Gore Range Capital adds world-class advisory board members to new skin health venture capital fund
From
Business Wire News Releases
JAMA Dermatology Publishes Results from Verrica’s Two Pivotal Phase III CAMP (Cantharidin Application in Molluscum Patients) Trials
September 23, 2020
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.